文献速递脑血管病

14,15-EET通过维持线粒体稳态抑制缺血性卒中后神经元焦亡

14,15-EET Maintains Mitochondrial Homeostasis to Inhibit Neuronal Pyroptosis After Ischemic Stroke.
PubMed 文献 · Stroke · 2025-04-16

该研究在小鼠大脑中动脉闭塞再灌注模型及HT22细胞氧糖剥夺/复氧模型中,探讨14,15-EET对线粒体稳态和神经元焦亡的调控作用。结果显示14,15-EET减少脑梗死体积、改善神经功能恢复,抑制NLRP1、IL-1β、caspase-1和GSDMD上调,增加Parkin和LC3B表达,并激活WNT信号通路。WNT抑制剂XAV-939可减弱上述效应。

要点

  • 14,15-EET减少小鼠脑缺血再灌注后脑梗死体积并改善神经功能恢复。
  • 14,15-EET维持缺血半暗带神经元形态结构及树突棘密度。
  • 14,15-EET通过激活WNT信号通路上调Parkin依赖的线粒体自噬,抑制神经元焦亡。

核心结论

  • 14,15-EET通过调控线粒体稳态抑制神经元焦亡,从而促进小鼠脑缺血再灌注后神经功能恢复。

研究设计与样本

  • 研究采用小鼠大脑中动脉闭塞再灌注动物模型,于再灌注后1、3、5天评估神经功能。
  • 体外研究使用HT22细胞氧糖剥夺/复氧模型检测14,15-EET减少神经元焦亡的机制。

主要发现

  • 14,15-EET治疗减少小鼠脑缺血再灌注后脑梗死体积并改善神经功能恢复。
  • 14,15-EET治疗维持缺血半暗带神经元形态结构及树突棘密度。
  • 14,15-EET抑制脑缺血再灌注诱导的NLRP1、IL-1β、caspase-1和GSDMD上调,并增加线粒体自噬蛋白Parkin和LC3B表达。
  • 转录组分析发现14,15-EET通过激活WNT信号通路发挥神经保护作用,体内外均上调WNT1、WNT3A、β-catenin和p-GSK-3β。
  • WNT信号通路抑制剂XAV-939在氧糖剥夺/复氧及14,15-EET处理的HT22细胞中降低Parkin表达并上调caspase-1和GSDMD表达。

临床怎么用

  • 原文未给出临床转化推荐;研究结果提示14,15-EET可能通过维持线粒体稳态和抑制神经元焦亡促进脑缺血再灌注后神经功能恢复。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuronal pyroptosis is involved in neuronal cell death and neurological damage after cerebral ischemia-reperfusion. 14,15-Epoxyeicosatrienoic acid (14,15-EET) can reduce neuronal loss induced by cerebral ischemia-reperfusion by regulating mitochondrial biological processes. However, it remains unclear how 14,15-EET regulates mitochondrial homeostasis, inhibits neuronal pyroptosis, and promotes neurological functional recovery after cerebral ischemia-reperfusion. METHODS: Mice with middle cerebral artery occlusion and reperfusion were used as an animal model to study the cerebral ischemia-reperfusion disease. The neurological function of mice was performed at 1, 3, and 5 days to test the therapeutic effects of 14,15-EET. Transmission electron microscope imaging and Nissl staining were used to analyze neuronal morphological structure, mitophagy, and neuronal pyroptosis. Western blot and transcriptome were used to detect the levels of mitophagy and neuronal pyroptosis signaling pathway-related molecules. HT22 cells were used in in vitro studies to detect the mechanism by which 14,15-EET reduces neuronal pyroptosis after oxygen-glucose deprivation/reoxygenation treatment. RESULTS: 14,15-EET treatment reduced cerebral infarct volumes and improved neurological functional recovery in mice after cerebral ischemia-reperfusion. 14,15-EET treatment maintained the morphological structure of neurons in the ischemic penumbra area as well as the dendritic spine density in mice after cerebral ischemia-reperfusion. The upregulation of NLRP1 (NOD-like receptor thermal protein domain associated protein 1), IL (interleukin)-1β, caspase-1, and GSDMD (gasdermin D) induced by cerebral ischemia-reperfusion was inhibited, and the expression of mitophagy proteins Parkin and LC3B (microtubule-associated protein 1 light chain 3 B) was increased by 14,15-EET treatment. Transcriptome profiling found that 14,15-EET exerts a neuroprotection role in promoting neural function recovery by activating the WNT (wingless-type mouse mammary tumor virus integration site family) signaling pathway. We found that 14,15-EET upregulated the WNT pathway proteins such as WNT1, WNT3A, β-catenin, and p-GSK-3β (phosphorylation of glycogen synthase kinase 3β) in vivo and in vitro. The WNT signaling pathway inhibitor XAV-939 reduced the expression of mitophagy protein Parkin and upregulated the expression of caspase-1 and GSDMD in HT22 cells with oxygen-glucose deprivation/reoxygenation and 14,15-EET treatment. CONCLUSIONS: 14,15-EET regulates mitochondrial homeostasis to inhibit neuronal pyroptosis, thereby promoting the recovery of neurological function in mice after cerebral ischemia-reperfusion. These results provide new ideas for maintaining mitochondrial homeostasis and inhibiting neuronal pyroptosis after cerebral ischemia-reperfusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Geng H, Tang J, Li Z, et al. 14,15-EET Maintains Mitochondrial Homeostasis to Inhibit Neuronal Pyroptosis After Ischemic Stroke. Stroke. 2025. PMID: 40235438. doi:10.1161/STROKEAHA.124.049143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。